Crexavibart Antibody
Crexavibart (BMS-986413; C-144-LS) is an IgG1 λ2 monoclonal antibody that binds specifically to the SARS-CoV-2 spike protein's receptor-binding domain. It is a research tool for studying viral neutralization mechanisms and evaluating therapeutic candidates in both in vitro and in vivo models.
Product Specifications
Target
SARS-CoV
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
